| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 原料药系列(元) | 316,290,993.64 | 443,396,055.73 | 269,131,663.54 | 692,028,068.71 | 458,811,799.29 |
| 制剂药品系列(元) | 542,623,142.45 | 1,079,083,220.43 | 584,392,870.74 | 1,114,502,506.57 | 593,208,613.26 |
| 其他(元) | 2,857,359.04 | 3,763,510.57 | 2,071,319.22 | 7,738,333.61 | 4,735,725.12 |
| 营业成本(元) | |||||
| 原料药系列(元) | 212,304,159.14 | 276,380,476.55 | 178,432,387.57 | 599,526,284.16 | 397,360,901.45 |
| 制剂药品系列(元) | 163,326,688.53 | 411,997,905.95 | 225,783,484.03 | 428,875,829.45 | 217,395,572.85 |
| 其他(元) | 856,445.86 | 688,753.35 | 494,387.79 | 931,390.82 | 211,306.92 |
| 毛利(元) | |||||
| 原料药系列(元) | 103,986,834.50 | 167,015,579.18 | 90,699,275.97 | 92,501,784.55 | 61,450,897.84 |
| 制剂药品系列(元) | 379,296,453.92 | 667,085,314.48 | 358,609,386.71 | 685,626,677.12 | 375,813,040.41 |
| 其他(元) | 2,000,913.18 | 3,074,757.22 | 1,576,931.43 | 6,806,942.79 | 4,524,418.20 |
| 毛利率(%) | |||||
| 原料药系列(%) | 32.88 | 37.67 | 33.70 | 13.37 | 13.39 |
| 制剂药品系列(%) | 69.90 | 61.82 | 61.36 | 61.52 | 63.35 |
| 其他(%) | 70.03 | 81.70 | 76.13 | 87.96 | 95.54 |
| 收入构成(%) | |||||
| 原料药系列(%) | 36.70 | 29.05 | 31.46 | 38.14 | 43.42 |
| 制剂药品系列(%) | 62.97 | 70.70 | 68.30 | 61.43 | 56.13 |
| 其他(%) | 0.33 | 0.25 | 0.24 | 0.43 | 0.45 |
| 毛利构成(%) | |||||
| 原料药系列(%) | 21.43 | 19.95 | 20.12 | 11.78 | 13.91 |
| 制剂药品系列(%) | 78.16 | 79.68 | 79.53 | 87.35 | 85.07 |
| 其他(%) | 0.41 | 0.37 | 0.35 | 0.87 | 1.02 |